FARO ECONÓMICOSTOCK ANALYSIS

AVLN — analysis and forecast

$26.04-4.4% todayAvalyn Pharma Inc.
Verdict
Bearish
RSI (14)
46
MACD
▲ rising
Trend
Downtrend
Volatility
63%
52w range
17%

🧬 Faro multibagger DNA

Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.

52/ 100
Mixed

Strongest: Room to grow and Balance sheet. Most lacking: Business quality and Sales engine.

Room to grow100

Worth $1.2 B. To grow ×10 it would have to reach $11.5 B.

Sales engine35

Not enough sales data.

Business quality5

Gross margin 0%, operating margin 0%, return on equity —.

Cash it generates40

No free cash flow data.

Price vs. growth40

Trades at —× sales with no growth to back it.

Balance sheet100

Net cash equal to 29% of its value.

Faro seal50

No recent federal contracts on the radar · inside a Faro megatrend · insiders own 0.0%.

⏱️ Timing (not scored): near its 12-month low · below its 200-day average · trailing the S&P 500 by 23 points over 12 months.

Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayBearish46%$26.01 -0.1%$24.99 – $27.07
3 daysBearish45%$25.96 -0.3%$24.22 – $27.82
1 weekBearish45%$25.91 -0.5%$23.69 – $28.33
15 daysNeutral44%$25.78 -1.0%$22.71 – $29.25
1 monthNeutral42%$25.49 -2.1%$21.22 – $30.61
3 monthsBearish38%$24.42 -6.2%$17.78 – $33.54

Recent momentum: -7.3% over 20 days · -11.2% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for AVLN. You can look it up yourself at USASpending.gov or in the Government Sources hub.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 30 for $25 — included in Navigator and Admiral.

See all 30 reports →

❓ Frequently asked questions about AVLN

Could AVLN be the next NVIDIA?

Its Faro multibagger DNA is 52/100 (mixed): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.

How much has AVLN fallen in the last year?

Avalyn Pharma (AVLN) is down 11.7% over the period with data and trades at $26.04, 33.7% below its 52-week high ($39.25). 52-week range: $23.33 – $39.25.

How volatile is AVLN stock?

Its annualized volatility is around 63% and its worst drop from a peak over the last year was 40.6%. For reference, the S&P 500 usually moves 15–20% a year.

Does AVLN have U.S. government contracts?

There is no notable federal contract in Faro's register. You can search USASpending.gov.

Is now a good time to buy AVLN?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: bearish technical bias, RSI 46, price below its 50-day average and an estimated 42% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.